Methylome Analysis in Chickens Immunized with Infectious Laryngotracheitis Vaccine by Carrillo, José A. et al.
RESEARCH ARTICLE
Methylome Analysis in Chickens Immunized
with Infectious Laryngotracheitis Vaccine
José A. Carrillo1, Yanghua He1, Juan Luo1, Kimberly R. Menendez2, Nathaniel L. Tablante2,
Keji Zhao3, Joseph N. Paulson4, Bichun Li5, Jiuzhou Song1*
1 Department of Animal and Avian Sciences, University of Maryland, College Park, Maryland, United States
of America, 2 Virginia-Maryland Regional College of Veterinary Medicine, University of Maryland, College
Park, Maryland, United States of America, 3 Laboratory of Molecular Immunology, National Heart, Lung and
Blood Institute, National Institutes of Health, Bethesda, Maryland, United States of America, 4 Center for
Bioinformatics and Computational Biology, University of Maryland, College Park, Maryland, United States of
America, 5 College of Animal Science and Technology, Yangzhou University, Yangzhou City, Jiangsu
Province, P. R. China
* songj88@umd.edu
Abstract
In this study we investigated the methylome of chickens immunized with Infectious laryngo-
tracheitis (ILT) vaccine derived from chicken embryos. Methyl-CpG binding domain protein-
enriched genome sequencing (MBD-Seq) method was employed in the detection of the
1,155 differentially methylated regions (DMRs) across the entire genome. After validation,
we ascertained the genomic DMRs distribution and annotated them regarding genes, tran-
scription start sites (TSS) and CpG islands. We found that global DNA methylation
decreased in vaccinated birds, presenting 704 hypomethylated and 451 hypermethylated
DMRs, respectively. Additionally, we performed an enrichment analysis detecting gene net-
works, in which cancer and RNA post-transcriptional modification appeared in the first
place, followed by humoral immune response, immunological disease and inflammatory
disease. The top four identified canonical pathways were EIF2 signaling, regulation of EIF4
and p70S6K signaling, axonal guidance signaling and mTOR signaling, providing new
insight regarding the mechanisms of ILT etiology. Lastly, the association between DNA
methylation and differentially expressed genes was examined, and detected negative corre-
lation in seventeen of the eighteen genes.
Introduction
Infectious Laryngotracheitis (ILT) is a disease caused by the Gallid herpesvirus 1 (GaHV-1).
The disease spreads worldwide and presents a challenge for the poultry industry due to its det-
rimental economic impact. Morbidity varies from 50 to 100%, and mortality between 10 and
20%, reaching sometimes 70% of the flocks [1]. Mostly, ILT is associated with chicken in areas
of high poultry production but the disease also affects other birds such pheasants, peafowls and
turkeys [2]. After the incubation period of 6 to 12 days, infected birds could display different
symptoms, such as conjunctivitis, sinusitis and nasal discharge, bloody mucous exudate,
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continuous head shaking and hyperextension of the neck [3]. The course of the disease extends
from 10 to 14 days. Grave acute cases will die within a few days [3]. Although chickens could
fully recover in the mild cases, the loss in growth, meat quality and egg yield is significant [4].
Therefore, the ILT is being listed as one of the priority poultry diseases in USA.
ILTV diagnostic is based on symptomatology, lesions, histology and laboratory analysis
(PCR, ELISA) [5]. Vaccination is used to prevent the incidence of the disease in endemic
regions or in emergency situations. Attenuated live vaccines are administered intraocular at the
age of 4 to 6 weeks, and revaccination is normally performed at 14–16 weeks by drinking water
[6]. Since inoculation could cause “vaccinal laryngotracheitis” in immune compromised indi-
viduals, only healthy birds should receive the antigen [7]. Modified-live vaccines have been
linked to several problems including adverse vaccine reactions, increase virulence by successive
passages of the virus from bird to bird, and the possible harbor of latent virus in vaccinated
individuals [8]. All these reasons justify the avoidance of modified-live vaccines. Recently, a
recombinant vaccine has been released for commercial use [9]. Recombinant vaccines have a
promissory future because a single dose confers lifelong immunity and lack most of the unde-
sirable reactions. Despite all the benefits described before, massive utilization of recombinant
vaccine is still scarce. To devise improved methods for the diagnosis and control of the disease,
more studies are necessary for understanding better the onset, establishment and course of the
infection.
The ILTV presents a linear and double-stranded DNA. Its genome size is approximately
150 kb, containing 48% of GCs [3]. The genome is organized in unique short and long regions
surrounded by identical internal and terminal repeat sequences, encoding 80 open reading
frames [10]. So far, most of the studies in ILT have been focused on the viral molecular struc-
ture and differences among strains [11, 12]. Identification of those divergences permits to rec-
ognize new viral mutations with atypical clinical signs that redefine the known course of the
disease [4].
Obviously, the establishment of the infection involves an interaction between the virus and
the host. Nevertheless, many aspects from the host side are still unknown or superficially
described, although studies in vitro explored genomic host responses to virulent and vaccine
ILTVs in lung cells obtained from chicken embryos [13, 14]. Comparing vaccine and virulent
ITL, they only identified several differentially expressed genes, such as C8orf79, F10, NPY and
BMP2 [13]. However, similar research in vivo exploration has not yet been reported. Although
identification of genes explains part of the implicated immunological mechanisms, the epige-
netic regulation of ILTV infection is still unrevealed. As we know, it is essential to understand
in details the host response to vaccination and infection for potential development of novel
vaccines, which will be important to control ILT.
DNA methylation—a common epigenetic phenomenon—consists on the addition of a
methyl group to the cytosine or adenine DNA nucleotides. In mammals, DNAmethylation
mostly occurs in CpG sites and ranges from 60 to 90 percent [15, 16]. It has been associated
with repressive gene stage and plays a major role in many biological processes such as cells dif-
ferentiation, carcinogenesis, genomic imprinting, chromosome inactivation and expression
regulation [17]. Unmethylated CpGs aggregate in clusters denominated CpG islands, which
exist in the 5’ regulatory regions of many genes [18]. Notably, diagnostic and prevention of
tumors for different tissues were developed based on their methylation profile, indicating that
methylation pattern differs between normal and cancerous tissues [19, 20].
In this study we explored the DNA methylation profiles and identified differentially methyl-
ated regions (DMRs) between ILTV vaccinated and control chicken groups, using the methyl-
CpG binding domain protein-enriched genome sequencing (MBD-Seq) method [21]. Subse-
quently, we annotated the DMRs regarding their location to genes and CpG islands, and
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performed enrichment and pathways analyses. Finally, we found some genes that were differ-
entially expressed in RNA-Seq analysis and also overlapped with the identified DMRs associ-
ated to its correspondent promoter, and explored the relationship between DNAmethylation
and gene expression.
Results
Twelve libraries were constructed from the birds’ DNAs. Each condition (control and vacci-
nated) has three elute concentrations with two replications. Before euthanasia, the birds were
checked and all individuals from the vaccinated group showed mild to acute clinical signs. The
respective scores ranged from 0 to 3 and none of the birds received more than 3 during the
experiment. Accordingly, the control group scored 0 for all individuals. Two biological repli-
cates from each condition were used to extract tracheal DNA for the MBD-Seq analysis.
Table 1 shows the number of reads per sample, in which the control with high elute concentra-
tion has the less number of aligned reads, oppositely to the vaccinated and low concentration
that holds the largest number of aligned fragments. The percentage of alignment for all samples
ranged from 66.11 to 83.69 percent. Considering the samples by conditions (Control-Vacci-
nated) and replicates (1–2), and comparing individual samples within groups, it is consistent
that high elute concentration produces DNA fragments that align in a smaller proportion to
the reference genome.
For peaks detection, Table 2 shows the samples and the last column arrays the numbers of
peaks for each sample. This is helpful to compare the numbers of peaks between replicates,
demonstrating how well replications represent their corresponding biological condition. Sam-
ples with high salt concentration have the lowest number of peaks, ranging from 7,858 to
11,109. Medium and High concentrations behaved similarly with comparable peak numbers
for three members of these groups. Low concentration samples clustered in two groups of simi-
lar values.
To evaluate the data quality, we did occupancy analysis based on the cross-correlations of
each row using only the peak calling data (Fig 1a), indicating the similarity of peak scores and
serving as a technical quality control as well. The samples clustered based on concentration
instead on replication, excepting for the high concentration samples where they paired by repli-
cation and condition (HC1-HC2 and HV1-HV2), as is reflected in the larger correlation coeffi-
cient among these samples. Then, a binding matrix was generated using the read counts
instead of the previously used peak confidence scores (Fig 1b). The results show affinity scores
correlation (reads counts) in all possible binding locations. For most of the samples correla-
tions are higher than in Fig 1a. Obviously, this approach worked well for grouping high con-
centration samples by condition and replicates but failed to classify all samples based on
condition.
By using DiffBind, we defined a contrast based on conditions and detected 85,493 unique
peaks and 47,356 overlapped peaks. The resulting matrix of 47,356 x 12 represents binding
locations and number of samples for rows and columns, respectively. We detected 1,155 DMRs
across the entire chicken genome for birds that were inoculated with ILT chicken embryo ori-
gin vaccine. The differentially methylated regions (DMRs) (FDR<0.1) are presented as red
dots in the Fig 2a. We found that 451 and 704 DMRs were hypomethylated and hypermethy-
lated in the vaccinated group, respectively. The clustering of samples, using only the identified
DMRs, was shown in the Fig 2b. The extensive list of DMRs is provided as an excel spreadsheet
in the S2 Table. The results coincide with the condition of the samples, especially for the vacci-
nated samples that were assigned to the same cluster, suggesting that these DNA varying meth-
ylation levels could be used to predict the outcome of the individual.
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As for the distribution of the DMRs’ length, as shown in Fig 3a, we found the average was
1,215 with extreme values of 80 and 13,200 base pairs, respectively. Approximately more than
55% of the DMRs were less than 1,000 bp and only one percent of the DMRs accounted for
fragments longer than 4,000 bp. Fig 3b illustrates the number of DMRs per chromosome. Due
to the large number of unassigned locations in the chicken genome, the random chromosome
accounted for 222 regions, followed by chromosome one with 172 DMRs. Chromosomes 16,
22 and 25 had the lowest numbers of DMRs with values of 5, 5 and 6, correspondingly.
The binding affinity between conditions was shown in the Fig 4a. We found that global
DNAmethylation decreased in vaccinated individuals. The + sign marked the 451 sites with
increased affinity in the vaccinated group and the—sign for the 704 regions that also aug-
mented its binding, but in the control cluster. The gray and white boxes corresponded to con-
trol and vaccinated within + or—groups, correspondingly. To test whether the distribution of
the values was significantly different among them, a two-sided Wilcoxon-Mann-Whitney test
was applied. From the Table 3, all were significant different (p<0.05), excepting (Control.DB
+ versus Vacc.DB).
In order to assess the reliability and accuracy of MBD-seq in DMRs detection, 36 DMRs
were arbitrarily selected for validation. At least 10 colonies were cultured and then sequenced
Table 1. Sequencing andmapping details of the samples.
Sample Reads Processed Aligned Reads Unaligned Reads Aligned (%)
LowControl1 15,840,740 12,242,921 3,597,819 77.29
MedControl1 12,049,016 9,408,739 2,640,277 78.09
HighControl1 17,685,076 11,692,413 5,992,663 66.11
LowControl2 7,788,797 6,213,214 1,575,583 79.77
MedControl2 7,406,875 5,497,846 1,909,029 74.23
HighControl2 18,880,981 12,546,980 6,334,001 66.45
LowVac1 7,475,829 6,256,266 1,219,563 83.69
MedVac1 7,389,194 5,849,164 1,540,030 79.16
HighVac1 9,922,376 6,909,168 3,013,208 69.63
LowVac2 8,402,205 6,992,132 1,410,073 83.22
MedVac2 6,437,102 5,335,687 1,101,415 82.89
HighVac2 7,383,856 5,066,831 2,317,025 68.62
doi:10.1371/journal.pone.0100476.t001
Table 2. Description and number of peaks per sample.
ID Tissue Condition Treatment Replicate Peak caller Intervals
HC1 Trachea Control High 1 Macs 8,362
HC2 Trachea Control High 2 Macs 7,858
HV1 Trachea Vaccinated High 1 Macs 11,109
HV2 Trachea Vaccinated High 2 Macs 9,571
MC1 Trachea Control Medium 1 Macs 30,202
MC2 Trachea Control Medium 2 Macs 21,891
MV1 Trachea Vaccinated Medium 1 Macs 30,036
MV2 Trachea Vaccinated Medium 2 Macs 29,909
LC1 Trachea Control Low 1 Macs 31,995
LC2 Trachea Control Low 2 Macs 24,667
LV1 Trachea Vaccinated Low 1 Macs 24,833
LV2 Trachea Vaccinated Low 2 Macs 28,398
doi:10.1371/journal.pone.0100476.t002
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from each group. Twenty-two of those 36 DMRs (61%) had been sequenced. The calculated
methylation levels are shown in the Fig 4b. We found that methylation levels of 19 of these 22
DMRs (86.4%) agreed with the directionality of the change revealed by MBD-seq, although
only 36.8% of DMRs had significant differences (p< 0.01), detected by bisulfite sequencing.
This technic employs only a segment of the DMR to perform the validation, thus the orienta-
tion of the change is more descriptive than the magnitude of methylation differences. For
example, the methylation level of ILTV group was extremely higher than the control group for
the MBD22 region (FDR = 0.016), employing the MBD-Seq method. In this case, the MBD-Seq
result was accurate validated by the bisulfite sequencing approach (Fig 5).
The DMR annotation was subsequently performed (S3 Table). The distribution of DMRs’
distances to the closest Transcription Start Site (TSS) can be seen in the Fig 6a, demonstrating
that approximately 60% of the DMRs are located within a range of 10,000 bp from the TSS.
Moreover, DMRs location related to genes and CpG islands are summarized in the Fig 6b. We
Fig 1. Heat-maps obtained at different stages of the analysis a) Occupancy analysis result based on rows cross-correlations from the peaks detected by
MACS. The dendogram describes the similarity of peaks among samples and serves as a quality control for the peak calling step b) Clustering employing the
reads counts of each sample in the entire set of potential binding sites, which are represented by rows in the matrix.
doi:10.1371/journal.pone.0100476.g001
Fig 2. Differentially methylated regions visualization and cluster of samples considering their methylation levels a) The MA plot shows in red the differentially
methylated regions obtained with a false discovery rate of < 0.1 b) Heat-map of samples demonstrates a perfect classification of the condition of the
individuals based on methylation levels in the differentially methylated regions.
doi:10.1371/journal.pone.0100476.g002
Methylation and ILTV Infection
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found that almost half of the DMRs are contained within genes and a quart in regions
upstream the TSS; fragments located behind the end of the genes account for 16%. Because the
chicken genome is well annotated and considers small genes, 30 of these reside within DMRs
(includeFeature). Regarding CpG islands, as shown in the Fig 6b, the situation is different, 76%
are outside the GpG island boundaries and 12% of the annotated CpG islands are included in
the DMRs. Because CpG islands are normally unmethylated and have been found inside or
near approximately 40% of mammalian promoter regions, i.e., most of DMRs are located
upstream and downstream of CpG islands.
There is evidence that some promoters can initiate transcription in both directions, affecting
the expression of more than one protein coding gene [22]. For this reason, we explored the dif-
ferentially methylated regions to identified genes with bi-directional promoters, using 5,000 bp
as the parameter for maximum distance. From the 1,155 identified DMRs, 165 are located
Fig 3. Length and chromosomal location frequencies of the DMRs a) DMRs' length density. The abscissa represents the extent of the DMRs in base pairs.
The dashed and dotted lines correspond for the median and mean respectively b) Distribution of the Differentially Methylated Regions per chromosome
without normalization (ignoring chromosome length).
doi:10.1371/journal.pone.0100476.g003
Fig 4. Binding sites reads counts and comparison of bisulfite sequencing and MBD-Seq approaches a) Normalized reads in binding sites per condition. The
first two boxplots represent the overall methylation level in the control and vaccinated groups. The boxplots marked with the + and - signs correspond to the
DMRs with enriched methylation levels in the vaccinated and control clusters, accordingly b) DNAmethylation levels expressed in -log2 fold change from
bisulfite sequencing (y-axis) and MBD-Seq (x-axis) methods.
doi:10.1371/journal.pone.0100476.g004
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PLOS ONE | DOI:10.1371/journal.pone.0100476 June 24, 2015 6 / 17
within bi-directional promoters, accounting for 14.2% of the total. The list of peaks associated
with bi-directional promoters is provided (S4 Table).
Using the genes identified from the annotated peaks, gene ontology enrichments and Inge-
nuity Pathway Analysis (IPA) were performed. The resultant top-notch networks were: a) Can-
cer, hematological disease, RNA pot-transcriptional modification; b) Hematological system
development and function, humoral immune response, cellular assembly and organization; c)
Hematological disease, immunological disease, inflammatory disease; d) Protein synthesis,
cancer, hematological disease; e) Molecular transport, protein trafficking, cell cycle. Regarding
molecular and cellular functions, the distinguished were: a) Cellular growth and proliferation;
Table 3. Wilcoxon-Mann-Whiney test for the differentially methylated regions.
Cont.DB Vacc.DB ContDB+ Vacc.DB+ Cont.DB- Vacc.DB-
Cont.DB 1 1.06e-43 1.47e-29 3.13e-03 4.49e-17 1.46e-67
Vacc.DB 1.06e-43 1 2.83e-01 1.33e-25 2.15e-57 6.93e-15
Cont.DB+ 1.47e-29 2.83e-01 1 1.28e-75 3.50e-65 7.40e-14
Vacc.DB+ 3.13e-03 1.33e-25 1.28e-75 1 3.54e-06 3.17e-56
Cont.DB- 4.49e-17 2.15e-57 3.50e-65 3.54e-06 1 6.39e-117
Vacc.DB- 1.46e-67 6.93e-15 7.40e-14 3.17e-56 6.39e-117 1
doi:10.1371/journal.pone.0100476.t003
Fig 5. Bisulfite sequencing validation of MBD-Seq result (e.g., MBD22 region) a) Methylation concentration levels fromMBD-seq b) Bisulfite
sequencing results. Each line represents a plasmid sequence and each dot indicates a CpG site. An open circle indicates an unmethylated CpGs and a
black dot methylated CpGs. The double-cross shape was the mutation. The methylation level was calculated as the number of methylated CpG sites divided
by the total detected CpGs (mutation excluded).
doi:10.1371/journal.pone.0100476.g005
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b) Cell death and survival; c) Cellular assembly and organization; d) Cellular function and
maintenance; e) Cellular development. The top canonical pathways with its correspondent p-
value and ratio are summarized in the Table 4. According to the p-value, the most significant
ones are for EIF2 Signaling and regulation of eIF4 and p70S6K signaling pathways. PI3K Sig-
naling in B Lymphocytes shows the highest p-value among the top five canonical functional
pathways.
To explore the relationship between DNAmethylation and gene transcription, comparison
between differentially expressed genes—RNA-Seq analysis—from a previous study [23] and
DMR annotated genes, was carried out. We detected 22 common entities from an original list
of 173 genes with divergent gene expression. As shown in the Fig 7a, the relationship of expres-
sion levels for these genes in vaccinated and control birds was found. Notably, 21 of the 22
common genes were upregulated in the vaccinated group. However, to further explore the rela-
tionship between methylation level in promoters and gene expression, we identified the peaks
that overlap with promoters (± 5 kb from the TSS), and plotted gene expression against meth-
ylation level. From the Fig 7b, we found 17 of those 18 genes had high methylation with low
gene expression in the control group, meaning that these genes were up regulated in the vacci-
nated birds. ENSGALG00000006591 was the only gene that decreased its expression concur-
rently with methylation in the vaccinated birds (Fig 7b). Some genes presented more than one
annotated DMR, i.e., gene ENSGALG00000021139 contained the maximum number of DMRs,
allocating four in its body and the fifth overlapping the end of the gene. For
Fig 6. Frequency of DMRs’ distances to closest Transcription Start Site and DMRs location distribution regarding genes and CpG islands. a) The
distance from the transcription start site is represented in base pairs from the 0 in the x-axis b) The labels in both pies represent: inside, DMR contained within
the feature; include feature, the genomic feature is entirely included in the DMR; overlap start, the DMR extend over the start site of the feature; overlap end,
the ending site of the feature overlaps with the DMR; downstream, DMR locates downstream the feature; upstream, the DMR aligns upstream the genomic
feature.
doi:10.1371/journal.pone.0100476.g006
Table 4. Canonical Pathways identified using IPA analysis.
Pathway Name p-value Ratio (%)
EIF2 Signaling 1.57e-28 46/201 22.9
Regulation of eIF4 and p70S6K Signaling 1.08e-08 21/175 12
Axonal Guidance Signaling 9.1e-07 34/483 7
mTOR Signaling 9.57e-07 21/213 9.9
PI3K Signaling in B Lymphocytes 3.92e-06 16/143 11.2
doi:10.1371/journal.pone.0100476.t004
Methylation and ILTV Infection
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ENSGALG00000002160, ENSGALG00000005941, ENSGALG00000009594, ENSGALG0000
0022847 and ENSGALG00000023372 two DMRs were identified. The rest of the genes have
unique DMRs. In contrast, some of the regions with distinct methylation levels affect not only
a single gene promoter region, e.g., ENSGALG00000005919, ENSGALG00000005941 and
ENSGALG00000021139 share the same DMR. For this regard, we only identified 19 unique
DMRs, corresponding to the 18 previous reported differentially expressed genes.
Discussion
Today, DNA methylation is one of the best-recognized epigenetic marks, which are mostly
associated with heterochromatin and repressive state of gene [24]. Thus, the identifications of
epigenetics marks are of important values on developmental, growth and disease diagnose. So
far, there have been several methods applied to DNA methylation analysis [25]. Among them,
MBD-Seq constitutes a good alternative for detection of DNA methylation in genome wide
studies [21]. The method is cost-effective and not affected by the specificity of antibodies,
because it relies in affinity of the protein MBD2. Particularly, MBD-Seq employs different salt
concentrations to elute the fragments regarding their methylation density. However, the opti-
mum number of salt cuts depends on the experiment requirement. In the present, three con-
centrations were enough to cover most of the methylated regions. MBD-Seq requires similar
sequencing depth as MeDIP to detect around 70–80% of the CpGs in the human genome [26].
Currently, bisulfite conversion methods (i.e.: MethylC-Seq) are the gold standard for methyla-
tion detection but the cost and demanded labor still prohibits its massive use for genome wide
screenings [27, 28]. In the ILTV infection, the 1,155 detected DMRs characterize the difference
in DNAmethylation patterns between control and vaccinated birds. We know that many phys-
iological changes occur after an organism is exposed to an antigen; however, the role of DNA
methylation in the complex mechanisms of immunological response is not well understood.
Owing to three levels of salts used in the MBD-Seq analysis, the different salt concentration
varies binding affinity related to CpG islands density. As expected, high concentration elutes
have the less number of detected peaks. This finding agrees with the fact that only few genomic
regions presents high CpGs frequency [29]. The numbers of peaks within each concentration
were considerable homogeneous, demonstrating the consistency of the applied peak calling
method.
Fig 7. Gene expression of commonly detected genes and expression-methylation relationship. a) Relative gene expression of twenty-two common
genes detected by both methods (Annotation of the Differentially Methylated Regions and RNA-Seq analysis) in vaccinated against control birds b) Gene
expression and methylation level of its correspondent peaks. The points that perfectly align to the ordinates, are different genes assigned to a singular DMR.
Observations with the same gene expression value but diverse methylation levels correspond to several DMRs contained within a gene.
doi:10.1371/journal.pone.0100476.g007
Methylation and ILTV Infection
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As we know, DNA methylation has an main role in cancer and other pathologies [30]. It is
also recognized that methylation of promoters leads to inactivation of tumor repressor genes in
different cancer types [31]. However, global hypomethylation promotes genomic instability,
producing aberrant cell transformations observed in cancer [32, 33]. In this research, we found
that DNA methylation globally decreased in vaccinated birds. The data coincided with early
reports in Marek’s Disease and suggests that for individuals to be capable to respond to an anti-
gen inoculation, genes involved in the immunological response should be activated [34, 35].
Nevertheless, in order for this to happen repressive marks as DNAmethylation must be
removed. Although this occurred in most of the DMRs, 451 regions presented an increment in
DNAmethylation. These regions can be related to the genes that actively repress the immune
machinery under normal conditions, but are silenced to release the immune response in other
circumstances. Notably, identified DMRs were in average 1,215 bp long. However almost 60%
were shorter than 1,000 bp and only 1% could reach 4,000 bp or more (Fig 3a). This suggests
that methylation in relatively small fragments of DNA is sufficient to regulate gene activity and
ultimately influence biological functions. Visualization of the DMRs’ chromosomic distribu-
tion shows that the largest number of DMRs was assigned to unspecific locations in the ran-
dom chromosome. Chromosome 1 allocated the second larger number with 172 divergent
methylation fragments, and chromosomes 16 and 22 with no more than 5 DMRs (Fig 3b).
Although the DMR numbers are not normalized regarding chromosome length, we can see the
bigger chromosomes contain the more numbers of DMRs.
Promoter are normally localized close to their respective gene, extending from 100 to 1000
bp [36]. Also, evidence showed that gene promoters display chromosome-specificity and reveal
chromosome territories [37]. Accordingly, we analyzed the distance of the DMR to the TSS of
the closest gene, considering the transcription direction. We found most of the DMRs sur-
rounded the TSS within 10 kb. The second largest group allocating almost 250 DMRs are
upstream the TSS, confirming previous findings [38, 39]. Interestingly, bidirectional promoters
can trigger transcription in both directions. Moreover, non-coding transcription at promoters
can influence protein-coding genes, suggesting a new level mechanisms of regulation [22]. In
the present we detected 165 genes that are located closely to bidirectional promoters. Further
studies should be performed to analyze the relationship between them and their products, to
determine whether they display co-regulation or not, and to reveal more details about tran-
scription regulation in this specific case. Almost 50% of the DMRs reside inside genes, the sec-
ond largest group is “upstream” followed by the “downstream”. The chicken genome is well
annotated comparing to other agricultural species, thus small genes as microRNA are included
in the annotation [40]. Some of these small RNAs are totally contained in the DMRs. The com-
ponents of this group could constitute another layer of gene regulation, the post-transcriptional
regulation mediated by microRNAs.
Although vertebrate genomes normally show depletion in CG sites, many regions allocate
CpG islands [41]. Portions of the genome, that range from 300 to 3000 bp with a high content
of G+C and high frequency—more than expected by chance—of CpG dinucleotides are defined
as CpG islands. Usually they contain at least 200 bp and a GC content more than 50% and an
observed-to-expected CpG ratio exceeding 60% [42]. CpG islands were associated with the 5’
end of all housekeeping genes and many tissue-specific genes, and some 3’ end of tissue-spe-
cific genes [41]. Small number of genes has both 5’ and 3’ CpG islands, distant by several kilo
bases of DNA depleted in CpG dinucleotides [43]. Methylated cytosine tend to transform into
thymine thus CpG sites are rare in vertebrates; this explains why CpG islands turn to be most
of the time unmethylated. In case methylation occurs, it happens in CpG island shores rather
than the islands themselves [21]. Methylation of CpGs in promoters’ CpG islands has been
associated with a repressive gene expression.
Methylation and ILTV Infection
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Interestingly, in functional analysis cancer related pathways appeared in the first four top
networks, although ILT lacks tumors compared to Marek’s disease, suggesting that genes
affected by DNAmethylation suffer aberrant cell regulation with oncogenic outcomes. Other
networks based on the score are relevant to RNA post-transcriptional modification, humoral
immune response, cellular assembly and organization, immunological and inflammatory dis-
eases, protein synthesis, molecular transport and cell cycle. Most of them also associate with
the immunological response after vaccination. Notably, among the canonical pathway analysis,
the most significant was eukaryotic translation initiation factor 2 (EIF2) signaling. Protein syn-
thesis requires various translation factors to initiate the process [44]. EIF2 is a GTP-binding
protein that accompanies the initiation of met-tRNA onto the ribosome and participates in the
recognition of the translational start site. Different stimuli can influence EIF2, which finally
modulate mRNA translation. Phosphorylation of EIF2-a terminates global translation and
causes apoptosis. The next significant pathways are regulation of EIF4 and p70S6 Signaling.
Since the recruitment of mRNA to the ribosomes is modulated by EIF4, several stimuli, such as
cytokines and growth factors PI3K, PDK1, AKT and mTOR, control EIF4 and p70S6K by
phosphorylation cascades [45]. Due to mTOR producing phosphorylation in many different
targets they are related to initiation of protein synthesis and reduction of protein translation
[46]. Most importantly, mTOR centrally modulates proliferative signal transduction, it was
nominated as the ideal target for cancer treatment [47].
As we know, cell migration is critical and occurs during immunological response after vacci-
nation, especially for ILT. In terms of functions of Ephrin B signaling and Phosphoinositide-
3-Kinases (PI3K) both modulate several processes such as cell growth, survival, differentiation,
metabolism and migration. Therefore, disruption of the PI3K signaling in the immune system
could cause immunodeficiency whereas unrestricting signals produces leukemia or autoim-
mune diseases [48]. Considering all pathways discussed above, the results suggests that a more
exhaustive analysis of the components is necessary for control of ILT infection.
In a combinational analysis between transcriptome from RNA-Seq and the DMR regions,
we identified some immune-related genes, such CD74 (ENSGALG00000004594), B2M
(ENSGALG00000002160) and LV1L2, (ENSGALG00000021139). Among them, CD74
encoded a MHC II protein acting as a chaperone modulating antigen presentation and serving
as a receptor in the cell surface for the cytokine macrophage migration inhibitory factor (MIF)
[49]. Interestingly, B2M (Beta 2 Microglobulin), codes for a protein founded in the serum asso-
ciated with the MHC I heavy chain [50]. B2M mutation causes hypercatabolic hypoproteine-
mia while the protein coded by GGA.47846 interacts selectively with protein complex to
counteract the effect of the antigen [51]. Similar to GGA.47846, gene Immunoglobulin lambda
chain V-1 region-like 2 (LV1L2) also participates in the immune response. Gene 5_8S_rRNA
encodes a noncoding RNA found in the ribosome that participates in protein synthesis [52].
Definitely, a lot of questions remain unexplainable regarding the role of DNAmethylation dur-
ing the immune response after vaccination. However, the goal of this study was to describe the
different DNAmethylation profiles between these two conditions.
In summary, we reported the first methylome profile related to vaccination in ILTV infec-
tion in birds. We found the global DNA methylation was decreased in vaccinated birds. In the
identified 1,155 DMRs, we found 451 hypermethylated and 704 hypomethylated DMRs in vac-
cination experiment, respectively. After annotation, the identified biological pathways were
mostly involved in the immune response post vaccination. Meanwhile, we also explored the
relationship between DNAmethylation and gene expression. The present study constitutes a
first detailed DNAmethylome profile in immunized chicken with ILT (CEO) vaccine, which
open opportunities for novel targets in prophylaxis and further provide new insights for future
studies regarding the role of epigenomic marks during immunological response.
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Material and Methods
All chickens were obtained from Charles River Laboratories. They consist in ten, 15 day-old
White Leghorn chickens that were randomly assigned to groups of five birds each. After 6
days, the control group received only sterile vaccine diluent (50 μl per nostril and 50 μl per eye,
for a total dose of 200 μl per animal) and then allocated in a separated animal room. Later, the
vaccine was prepared following the manufacturer’s recommendations and the vaccination was
performed in the second group. The procedure was the same as for the control group, except-
ing for the viral load (3.3 x 103 pfu). The vaccinated birds were placed in an animal isolator in
another suite.
Ethics Statement
All animal experiments were conducted following NIH guidelines for housing and care of labo-
ratory animals and in accordance with The University of Maryland at College Park (UMCP)
regulations after review and approval by the UMCP Institutional Animal Care and Use Com-
mittee (permit number R-08-62).
Vaccine Description
We used the modified live chicken-embryo origin vaccine, Trachivax and prepared the vaccine
solution according to the manufacturer’s instructions for ocular administration [53]. The vac-
cine was titrated in kidney cells obtained from 20-day-old pathogen free chicken embryos.
Dilutions of the vaccine ranged from 10–1 to 10–5. Four replications for each dilution were
inoculated into 12-well plates with 100% chicken-embryo kidney cell confluence for 1 hour.
Immediately, cells were washed with sterile phosphate buffered solution (PBS) and covered
with 0.8% methylcellulose in MEM D-Valine media (Promo Cell, C-75100), containing 2%
fetal bovine serum (HyClone Laboratories, SH30071), 1% sodium pyruvate (Invitrogen,
11360070) and 1% L-glutamine (Sigma-Aldrich, G7029). After 96 hours of incubation at 37°C
plaque forming units were counted for viral quantification.
Symptoms and Clinical Scoring
Birds were monitored daily, starting the day of inoculation. Any observed abnormality was
accurately recorded and the chickens were classified according to the following criteria: 0 (nor-
mal), 1 (mild eye inflammation), 2 (oculo-nasal discharge), 3 (coughing and sneezing) and 4
(expectoration of bloody mucous or respiratory distress)
Sample Collection
At 6-day post infection, all chickens were humanely euthanized following the IACUC guide.
Immediately, thoracic cavities were accessed and the trachea carefully dissected. Employing
sterile instruments for individual samples, each trachea was completely incised longitudinally
and the mucosa exposed. Finally, the tracheal mucosa was scraped from the larynx to the syrinx
using a sterile disposable scalpel. Samples were placed in individual identified tubes filled with
RNA later solution (QIAGEN, 76106) at -80°C for DNA or RNA extraction.
DNA extraction and MBD-Seq library preparation
Genomic DNA from five samples of each group was extracted using the Wizard Genomic
DNA purification kit (Promega, A1120). DNA concentration was measured by the Qubit
dsDNA Broad-Range Assay (Invitrogen, Q32850). Two DNA samples were randomly selected
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from each group and named as Control 1, Control 2, Vaccinated 1 and Vaccinated 2,
respectively.
MBD-seq method was used to identify methylated DNA regions. MethylCap kit (Diage-
node, C02020010) was employed to obtain DNA containing methylated CpGs. Firstly, DNA
was extracted and dissolved to reach 0.1μg/μl for a final volume of 40 μl in a 1.5 ml tube. Then
DNA was sheared into 300–500 bp fragments using the Bioruptor Sonicator and checked on
agarose gel to visualize the size of the resultant segments. Secondly, 141.8 μl of capture reaction
mix without MethylCap protein, but containing 12 μl of sheared DNA was prepared. From this
preparation, 119 μl of capture reaction mix was incubated with 1 μl of diluted MethylCap pro-
tein at 40 rpm on a rotating wheel for 2 hours and at 4°C to let the interaction occurs. The rest
(22.8 μl) was used later as input sample. Magnetic beads (coated with GSH) captured methyl-
ated DNA. After, unbound DNA was washed off and DNA elutes collected. For the elution,
150 μl of low, medium, and high concentration buffer was used serially per each capture. All
fractions and input were purified using the MiniElute PCR Purification Kit (QIAGEN, 28006).
Finally, qPCR (iCycler iQ PCR system, Bio-Rad) was performed in duplicates for each sample
to test the enrichment efficiency. Tested primers are listed in S1 Table. Method 2-ΔΔCt was
applied to determine relative fold enrichments; comparing enrichment values of a positive
TGFB3 to a negative primer pairMON2, between experimental (methyl DNA) and reference
(input DNA) samples.
The library for sequencing was constructed as follows. NEBNext End Repair Module (NEB,
E6050S) was used for the end repair of the fragmented methylated DNA. Then a 3’ A was
added using DNA Polymerase I, Large (Klenow) Fragment (NEB, M0210L). Also, a pair of
Solexa adaptors (Illumina) was ligated to the repaired ends by T4 ligase (Promega, M1801). Fil-
tration in a 2% agarose gel was used to select fragments (DNA plus adaptors) from 200 to
500bp. PCR enriched purified DNA templates by using Phusion Hot Start High-Fidelity DNA
Polymerase (NEB, M0530S). After purification, DNA quality was examined. The DNA library
was diluted and the concentration double-checked using the Qubit assay (Life Technology,
Q32850). Finally, we performed sequencing analyses in the Solexa 1G Genome Analyzer (Illu-
mina) following manufacturer protocols.
MBD-Seq Data Analysis
Sequence files were examined for quality assurance. After an adequate quality confirmation,
files were aligned to the galGal3 (WUGSC 2.1) reference genome obtained from the UCSC
browser (http://genome.ucsc.edu). For the alignment process, Bowtie (Ultrafast, memory-effi-
cient short read aligner) was employed [54]. Original fragments consisted in 50 nucleotides
although the first 15 5’ nucleotides of each fragment were trimmed to maintain high sequence
quality. For data manipulation, filtration and format conversion a combination of procedures
available in SAMtools and BEDtools were applied [55, 56]. An important step that should be
considered is the removal of duplicated reads, which has been achieved using the bRemoveDu-
plicates option included in the DiffBind package. This action will affect posterior procedures
and is critical for the analysis method that we used.
The peak-calling step was applied individually for each sample using Model Based Analysis
of ChIP-Seq (MACS) [57]. The software empirically models the shift size of the tags and
employs a dynamic Poisson distribution to account for local bias, making the predictions more
reliable. Identification of the Differentially Methylated Regions (DMRs) was accomplished
implementing the DiffBind R package [58]. It computes differentially bound sites using affinity
data. The set of peaks identified by MACS and the bam files containing aligned reads for each
sample, was the input for DiffBind. The program creates a matrix with the consensus peaks; for
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this case it was obtained with a “minimum overlap” of 2, determined by the number of replica-
tions in the experiment. After creating a contrast between conditions and considering concen-
tration as a block effect, DiffBind runs an edgeR analysis, which is an empirical Bayes method
[59]. For normalization, the default method TMM (Trimmed Mean of M-values) that subtracts
the controls reads and considers the effective library size (reads in peaks), was applied. The
threshold utilized was 0.1, for False Discovery Rate (FDR).
For the genomic annotation of the DMRs, the software ChIPpeakAnno was used [60].
ChIPpeakAnno provides information about the overlaps, relative position and distances for
the inquired feature. The annotation information was obtained from biomart, using Ensembl
70 in the archive site. Dataset “ggallus_gene_ensembl” corresponds to WASHUC2 (galGal3),
the genome used for alignment. The CpG island annotation was retrieved from UCSC web
browser. For the enrichment analysis, genes that were annotated based on the nearest TSS or
overlaps with the peaks were considered. An Interactive Pathway Analysis (IPA) was per-
formed using the Ingenuity software (http://www.ingenuity.com). The analysis generated an
extensive report, but the most valuable are: networks, diseases and disorders, molecular and
cellular functions, physiological system development and function, and canonical pathways.
Bisulfite Sequencing for MBD-seq Validation
Sodium bisulfite conversion reagents were used to treat 500 ng of DNA (EZ DNAMethylation
Golden Kit, ZYMO Research, D5005) following the standard protocol provided by the manu-
facturer. PCR primers were designed using MethPrimer (http://www.urogene.org/cgi-bin/
methprimer/methprimer.cgi) and listed in S1 Table. Firstly, equal amounts of DNA from five
samples of each group (vaccinated and control) were pooled together, serving as a template for
the bisulfite conversion and the bisulfite PCR. Then, PCR resultants were purified using QIA-
quick Gel Extraction Kit (QIAGEN, 28704). The purified PCR products were ligated to
pGEM-T Vector (pGEM-T Vector System I, Promega, A1360), transformed to DH5α compe-
tent cells (Z-Competent E. Coli Cells—Strain Zymo 5α, ZYMO Research, T3007), and screened
for successful insertions (blue-white selection) after incubation at 37°C overnight. In the next
step, ten white colonies from each group were cultured overnight in a 37°C shaker. Plasmid
DNA was isolated using Zyppy Plasmid Miniprep Kit (ZYMO Research, D4036). M13 reverse
primer and BigDye Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems, 4337456) was
employed for sequencing in the ABI 3730 machine. Bisulfite sequencing results were analyzed
by QUMA (http://quma.cdb.riken.jp) and DNA methylation level for each region and group,
obtained.
Supporting Information
S1 Table. PCR Primer sequences used for MBDSeq validation.
(DOCX)
S2 Table. Descriptors and statistics of differentially methylated regions (DMRs) identified
by MBDSeq method.
(XLS)
S3 Table. Annotation of the differentially methylated regions (DMRs) regarding Ensembl
genes.
(XLS)
S4 Table. Identified bi-directional promoters and its corresponding Ensembl annotation.
(XLS)
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